FDA Inspection 1093250 — Zhejiang Huahai Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Huahai Pharmaceutical Co., Ltd. on May 31, 2019 in Linhai. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- May 31, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Linhai (China)